MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Arcellx Incorporated (NASDAQ: ACLX)
Organization & Developments: Arcellx
Parents
Arcellx Incorporated (NASDAQ: ACLX)
Children
2025: Arcellx, Inc.: Trying To Build A Better Myeloma Cell Therapy
2025: Promising Potential of Arcellx Inc’s Anito-cel Therapy Drives Buy Rating_ www.tipranks.com
Arcellx is a clinical-stage biopharmaceuticalcompany developing adaptive and controllable cell therapies for the treatment of patients withcancer and autoimmune diseases.
Jumps
Finance & Acquisitions: Arcellx
Key People: Arcellx